(Q43872436)

27 November 2017

title

Maternal cfDNA screening for Down syndrome--a cost sensitivity analysis (English)

1 reference

27 November 2017

Howard Cuckle

1

1 reference

27 November 2017

Peter Benn

series ordinal

2

1 reference

27 November 2017

Eugene Pergament

series ordinal

3

1 reference

27 November 2017

publication date

9 June 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

33

1 reference

27 November 2017

issue

7

1 reference

27 November 2017

page(s)

636-642

1 reference

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study

27 November 2017

cites work

1 reference

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study

21 January 2018

1 reference

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing

21 January 2018

1 reference

Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.

21 January 2018

1 reference

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

21 January 2018

1 reference

Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors

21 January 2018

1 reference

Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma

21 January 2018

1 reference

NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy

21 January 2018

1 reference

ACMG statement on noninvasive prenatal screening for fetal aneuploidy.

21 January 2018

1 reference

Model-based screening by risk with application to Down's syndrome.

21 January 2018

1 reference

Age-standardisation when target setting and auditing performance of Down syndrome screening programmes.

21 January 2018

1 reference

Update on Procedure-Related Risks for Prenatal Diagnosis Techniques

21 January 2018

1 reference

Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PD.4157

1 reference

27 November 2017

1 reference